ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

Fermilab Treats 1,000th Patient

August 7, 1981

75% Of Fed Research Funds Pay Direct Costs, Study Says.

July 28, 2000

Bisphosphonates May Reduce Recurrent Breast Cancer

December 25, 2009

Waldmann, Columbia, Netherland, Receive Bristol-Myers Awards

April 17, 1992

DCE Board Approves Concepts For Three New RFA Programs

July 6, 1984

Hopkins, Pennsylvania Ok’d As Comprehensive; No. Remains At 24

May 24, 1991